Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mathis

Showing results (411-420 of 569) with videos related to

Pageof 57
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PETCharles M Laymon, N Scott Mason, W Gordon Frankle, et al.
Journal of Alzheimer'S Disease : JAD|April 12, 2021
An Effect of Education on Memory-Encoding Activation in Subjective Cognitive DeclineAkiko Mizuno, Helmet T Karim, Maria J Ly, et al.
The American Journal of Psychiatry|December 24, 2011
In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusersRajesh Narendran, Brian J Lopresti, Diana Martinez, et al.
Neuroscience Letters|April 28, 2005
Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's diseaseNicolaas I Bohnen, Daniel I Kaufer, Rick Hendrickson, et al.
Molecular Imaging and Biology|April 30, 2013
Development and screening of contrast agents for in vivo imaging of Parkinson's diseaseKrista L Neal, Naomi B Shakerdge, Steven S Hou, et al.
Neuroimage. Clinical|December 8, 2015
Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjectsJames M Mountz, Charles M Laymon, Ann D Cohen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 11, 2010
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography coreWilliam J Jagust, Dan Bandy, Kewei Chen, et al.
Nuclear Medicine and Biology|May 31, 2020
Development of a PET radioligand selective for cerebral amyloid angiopathyEric E Abrahamson, Jeffrey S Stehouwer, Alberto L Vazquez, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2010
A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatumRajesh Narendran, N Scott Mason, Charles M Laymon, et al.
Brain : a Journal of Neurology|October 12, 2007
Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's diseaseKerryn E Pike, Greg Savage, Victor L Villemagne, et al.
Pageof 57

Showing results (411-420 of 569) with videos related to

Sort By:
Pageof 57
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 18, 2009
Human biodistribution and dosimetry of the D2/3 agonist 11C-N-propylnorapomorphine (11C-NPA) determined from PETCharles M Laymon, N Scott Mason, W Gordon Frankle, et al.
Journal of Alzheimer'S Disease : JAD|April 12, 2021
An Effect of Education on Memory-Encoding Activation in Subjective Cognitive DeclineAkiko Mizuno, Helmet T Karim, Maria J Ly, et al.
The American Journal of Psychiatry|December 24, 2011
In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusersRajesh Narendran, Brian J Lopresti, Diana Martinez, et al.
Neuroscience Letters|April 28, 2005
Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's diseaseNicolaas I Bohnen, Daniel I Kaufer, Rick Hendrickson, et al.
Molecular Imaging and Biology|April 30, 2013
Development and screening of contrast agents for in vivo imaging of Parkinson's diseaseKrista L Neal, Naomi B Shakerdge, Steven S Hou, et al.
Neuroimage. Clinical|December 8, 2015
Comparison of qualitative and quantitative imaging characteristics of [11C]PiB and [18F]flutemetamol in normal control and Alzheimer's subjectsJames M Mountz, Charles M Laymon, Ann D Cohen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 11, 2010
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography coreWilliam J Jagust, Dan Bandy, Kewei Chen, et al.
Nuclear Medicine and Biology|May 31, 2020
Development of a PET radioligand selective for cerebral amyloid angiopathyEric E Abrahamson, Jeffrey S Stehouwer, Alberto L Vazquez, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2010
A comparative evaluation of the dopamine D(2/3) agonist radiotracer [11C](-)-N-propyl-norapomorphine and antagonist [11C]raclopride to measure amphetamine-induced dopamine release in the human striatumRajesh Narendran, N Scott Mason, Charles M Laymon, et al.
Brain : a Journal of Neurology|October 12, 2007
Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's diseaseKerryn E Pike, Greg Savage, Victor L Villemagne, et al.
Pageof 57